LobbyingNeurim Pharmaceuticals lobbying by quarter
Neurim Pharmaceuticals's latest lobbying report covers Q2 2026, at $60K. Its first report covers Q2 2026; the issues it reports most are Pharmacy.
Neurim Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $60K
- Last 2 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$60K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Polsinelli PC | $60K | 1 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/15for Q2 | Polsinelli PC | $60K |
| 05/05for Q2 | Polsinelli PC | Under $5,000 |